Global Hepatitis B Vaccines Market Size, Share, Trends and Forecast 2022-2030

Description

Hepatitis B vaccine is a vaccine that prevents hepatitis B.
Industry Insights

Due to the COVID-19 pandemic, the global Hepatitis B Vaccines market size is estimated to be worth US$ 1021.8 million in 2021 and is forecast to a readjusted size of US$ 1159.5 million by 2028 with a CAGR of 1.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Hepatitis B Vaccines market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Hepatitis B Vaccines landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.

The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.

Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report focuses on Hepatitis B Vaccines volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Hepatitis B Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, South Korea and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Hepatitis B Vaccines market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Yeast Derived

CHO Derived

Segment by Application

Children

Adult

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GSK

NCPC

Merck

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

TABLE OF CONTENT

1 Hepatitis B Vaccines Market Overview
1.1 Product Overview and Scope of Hepatitis B Vaccines

1.2 Hepatitis B Vaccines Segment by Type

1.2.1 Global Hepatitis B Vaccines Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Yeast Derived

1.2.3 CHO Derived

1.3 Hepatitis B Vaccines Segment by Application

1.3.1 Global Hepatitis B Vaccines Sales Comparison by Application: (2022-2028)

1.3.2 Children

1.3.3 Adult

1.4 Global Hepatitis B Vaccines Market Size Estimates and Forecasts

1.4.1 Global Hepatitis B Vaccines Revenue 2017-2028

1.4.2 Global Hepatitis B Vaccines Sales 2017-2028

1.4.3 Hepatitis B Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028

2 Hepatitis B Vaccines Market Competition by Manufacturers

2.1 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2017-2022)

2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Hepatitis B Vaccines Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Hepatitis B Vaccines Manufacturing Sites, Area Served, Product Type

2.5 Hepatitis B Vaccines Market Competitive Situation and Trends

2.5.1 Hepatitis B Vaccines Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Hepatitis B Vaccines Players Market Share by Revenue

2.5.3 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hepatitis B Vaccines Retrospective Market Scenario by Region

3.1 Global Hepatitis B Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Hepatitis B Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Hepatitis B Vaccines Market Facts & Figures by Country

3.3.1 North America Hepatitis B Vaccines Sales by Country

3.3.2 North America Hepatitis B Vaccines Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Hepatitis B Vaccines Market Facts & Figures by Country

3.4.1 Europe Hepatitis B Vaccines Sales by Country

3.4.2 Europe Hepatitis B Vaccines Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Region

3.5.1 Asia Pacific Hepatitis B Vaccines Sales by Region

3.5.2 Asia Pacific Hepatitis B Vaccines Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Hepatitis B Vaccines Market Facts & Figures by Country

3.6.1 Latin America Hepatitis B Vaccines Sales by Country

3.6.2 Latin America Hepatitis B Vaccines Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country

3.7.1 Middle East and Africa Hepatitis B Vaccines Sales by Country

3.7.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Hepatitis B Vaccines Historic Market Analysis by Type

4.1 Global Hepatitis B Vaccines Sales Market Share by Type (2017-2022)

4.2 Global Hepatitis B Vaccines Revenue Market Share by Type (2017-2022)

4.3 Global Hepatitis B Vaccines Price by Type (2017-2022)

5 Global Hepatitis B Vaccines Historic Market Analysis by Application

5.1 Global Hepatitis B Vaccines Sales Market Share by Application (2017-2022)

5.2 Global Hepatitis B Vaccines Revenue Market Share by Application (2017-2022)

5.3 Global Hepatitis B Vaccines Price by Application (2017-2022)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Corporation Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.1.4 GSK Hepatitis B Vaccines Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 NCPC

6.2.1 NCPC Corporation Information

6.2.2 NCPC Description and Business Overview

6.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.2.4 NCPC Hepatitis B Vaccines Product Portfolio

6.2.5 NCPC Recent Developments/Updates

6.3 Merck

6.3.1 Merck Corporation Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Merck Hepatitis B Vaccines Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Bio Kangtai

6.4.1 Bio Kangtai Corporation Information

6.4.2 Bio Kangtai Description and Business Overview

6.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio

6.4.5 Bio Kangtai Recent Developments/Updates

6.5 Dynavax

6.5.1 Dynavax Corporation Information

6.5.2 Dynavax Description and Business Overview

6.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Dynavax Hepatitis B Vaccines Product Portfolio

6.5.5 Dynavax Recent Developments/Updates

6.6 Hissen

6.6.1 Hissen Corporation Information

6.6.2 Hissen Description and Business Overview

6.6.3 Hissen Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Hissen Hepatitis B Vaccines Product Portfolio

6.6.5 Hissen Recent Developments/Updates

6.7 KM Biologics

6.6.1 KM Biologics Corporation Information

6.6.2 KM Biologics Description and Business Overview

6.6.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.4.4 KM Biologics Hepatitis B Vaccines Product Portfolio

6.7.5 KM Biologics Recent Developments/Updates

6.8 LG Life Sciences

6.8.1 LG Life Sciences Corporation Information

6.8.2 LG Life Sciences Description and Business Overview

6.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio

6.8.5 LG Life Sciences Recent Developments/Updates

6.9 Serum Institute

6.9.1 Serum Institute Corporation Information

6.9.2 Serum Institute Description and Business Overview

6.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio

6.9.5 Serum Institute Recent Developments/Updates

7 Hepatitis B Vaccines Manufacturing Cost Analysis

7.1 Hepatitis B Vaccines Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Hepatitis B Vaccines

7.4 Hepatitis B Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Hepatitis B Vaccines Distributors List

8.3 Hepatitis B Vaccines Customers

9 Hepatitis B Vaccines Market Dynamics

9.1 Hepatitis B Vaccines Industry Trends

9.2 Hepatitis B Vaccines Market Drivers

9.3 Hepatitis B Vaccines Market Challenges

9.4 Hepatitis B Vaccines Market Restraints

10 Global Market Forecast

10.1 Hepatitis B Vaccines Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Hepatitis B Vaccines by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Hepatitis B Vaccines by Type (2023-2028)

10.2 Hepatitis B Vaccines Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Hepatitis B Vaccines by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Hepatitis B Vaccines by Application (2023-2028)

10.3 Hepatitis B Vaccines Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Hepatitis B Vaccines by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Hepatitis B Vaccines by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample